Abstract:Mutations of the Wiskott-Aldrich Syndrome Protein (WASP) are responsible for a rare and severe disease: Wiskott-Aldrich Syndrome (WAS), including classic Wiskott-Aldrich Syndrome (WAS), X-linked thrombocytopenia (XLT), and congenital X-linked neutropenia (XLN). Classic WAS patients present typical WAS manifestation: eczema, thrombocytopenia, small platelet and recurrent infection, while XLT patients present thrombocytopenia, and XLN patients present congenital neutropenia. Bone marrow failure (BMF) is a series diseases characterized by pancytopenia in peripheral-blood(PB), different degree of bone marrow hypocellularity. In this study, we present two unrelated boys with pancytopenia who were admitted to our hospital on account of declining blood cells and different degree of hematopoietic failure. We identified a new WAS gene mutation C1378T inducing the WASP P460S mutation in both penitents by the second generation sequencing. Furthermore, one case developed T cell acute lymphoblastic leukemia (T-ALL) after severe pancytopenia recovered for 4 years and relapsed in mediastinum transplanted with cord blood for 1 year, another case recovered after haploidentical transplantation and kept stable for 1 year. To date, the role of WAS gene mutation in aplastic anemia-like hematopoietic failure remains unknown. We further verified WASP P460S mutation in these two patients by Sanger sequencing. In patient's PB cells, normal expression level of total WASP proteins was detected. This notion was different from general WASP deficiency classic WAS or XLT patients. To test the function of WASP P460S mutation in pancytopenia, we examined the effect of WASP P460S mutation on cell proliferation. Human myelogenous leukemia K562 cell line, which lacks endogenous WASP, was transfected with lentivirus vectors carrying mutant or wild type of WAS gene. We found that the cells expressing WASP P460S grew significantly slower than the cells expressing the wild type. Moreover, actin polymerization assay showed that increased actin polymerization function in WASP P460S mutation compared with wild type. In addition, P460S mutation had no obvious effect on Daunorubicin-induced apoptosis response. Our findings revealed that the WASP P460S mutation played a role in the inhibition of cell proliferation and actin polymerization which may lead to a new phenotype for WASP mutation related X-linked pancytopenia.

The diagnosis and treatment of Wiskott-Aldrich syndrome

Clinical characteristics and management of children with Wiskott-Aldrich syndrome

[Analysis of Clinical Features and Gene Mutations in 6 Patients with Wiskott-Aldrich Syndrome].

Wiskott-Aldrich Syndrome: A Report of a Rare X-Linked Disorder

Wiskott-Aldrich Syndrome Related Diseases

Identification of a novel WAS mutation and the non-splicing effect of a second-site mutation in a Chinese pedigree with Wiskott–Aldrich syndrome

A Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family

Two Cases of Wiskott-Aldrich Syndrome in Neonates Due to Gene Mutations

Wiskott-Aldrich syndrome: A new synonym mutation in the WAS gene

A novel WASP gene mutation in a Chinese boy with Wiskott–Aldrich syndrome

The Gene Mutation Analysis of a Wiskott-Aldrich Syndrome Family with Normal Mean Platelet Volume

Analysis of Correlation of WAS Gene Mutations with Clinical Phenotype

Mutational Landscape of Patients with Wiskott Aldrich Syndrome: Update from India

Wiskott-Aldrich Syndrome Protein Regulates Nucleolar Organization and Function in Innate Immune Response

Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report

A Novel Mutation in Wiskott-Aldrich Syndrome and Successfully Treated with Umbilical Cord Blood Transplantation

Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India

Facial Skin Lesions in a Boy With Wiskott-Aldrich Syndrome

The WASP P460S Mutation Causes a New Phenotype of WASP Mutations Related Disorder: X-Linked Pancytopenia

Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies

Analysis of curative effect by hematopoietic stem cell transplantation in the treatment of 5 Wiskott-Aldrich syndrome cases